4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline

DB03921ExperimentalSmall molecule

4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline: Overview.

Mechanism: Pharmacologically active on TGF-beta receptor type-1
Curator reviewed
Formula / weight: C₁₇H₁₂N₄ · 272.304 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyIBCXZJCWDGCXQT-UHFFFAOYSA-NSMILESN1C=C(C(=N1)C1=NC=CC=C1)C1=C2C=CC=CC2=NC=C1

Targets

What you can answer from here — as of September 19, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.